CD44 and ovarian carcinoma: CD44+ cells have been identified in primary tissues, metastatic tissues, and malignant ascites of ovarian cancer [36]; one hundred CD44+/CD117+ cells are sufficient to propagate the original tumor, but CD44-/CD117- cells are not [30].